Global Mycoplasma Testing Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

  • ID: 4263765
  • Report
  • Region: Global
  • 140 pages
  • Occams Business Research and Consulting
1 of 4

FEATURED COMPANIES

  • ATCC Company (U.S.)
  • Invivogen (U.S.)
  • Lonza Group (Switzerland)
  • Merck Millipore (U.S.)
  • Promocell Gmbh (Germany)
  • R&D Systems, Inc. (U.S.)
  • MORE
The global mycoplasma testing market is expected to grow with the CAGR of approximately 13.4% during the forecast period (2016-2023). The mycoplasma market is primarily driven due to various factors such as increasing funding for life science researches, increasing number of biotechnology & pharmaceutical firms, increasing demand for PCR based assays, increasing prevalence of mycoplasma infection across the globe and technological developments such as PCR technique. Commercial PCR tests having advantages in diagnosing M. pneumoniae infections as PCR is most reliable method for the detection of mycoplasma infection because it is not easy to culture mycoplasma on artificial media. Serology could be good and reliable screening tests for accurate diagnosis of M. pneumoniae. Numerous PCR methods based on 16SrDNA amplification comprise one- or two-step nested PCRs to identify mollicutes. Various methods is used for isolation of highly purified nucleic acids which is ideal for use in PCR and primarily used for detection of large number of samples. Increasing technological advancements enables to develop effectiveness and accuracy of testing and provides more accurate results. However, there are some factors restraining the market growth such as stringent government regulations and high cost associated with mycoplasma testing. Moreover, increasing healthcare spending in developing countries and growth in pharmaceutical outsourcing is creating opportunity for the mycoplasma testing market.

Geographically, North America is leading the mycoplasma testing market due to increasing focus on biopharmaceutical sector in the U.S. as well as better healthcare infrastructure for life science researches in the region. Furthermore, presence of major players such as Charles River Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Merck Millipore (U.S.), Lonza Group (Switzerland), Meridian Bioscience, Inc. (U.S.) etc. are creating opportunity for more technological developments in mycoplasma testing methods.

The global mycoplasma testing market is segmented on the basis of application, technology, end-user and product. The end-user segment is further classified into Cell banks, Academic research institutions, Contract research organizations, Pharmaceutical & Biotechnology companies and other end users. According to application, the mycoplasma testing market is further classified into cell line testing, virus testing, end of production cells and other applications. Cell line testing has led the largest revenue in 2016 due to increasing number of research activities undertaken for cell culture. Furthermore, increasing mycoplasma contamination in cell culture is also supporting to boost cell line testing application segment in the mycoplasma testing market. According to technology, the market is further segmented into PCR, DNA staining, Direct assay, Indirect assay, Enzymatic assay, Elisa and Microbial culture techniques. According to product segment, the market is further classified into Kits & Reagents, instruments and services.

Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ATCC Company (U.S.)
  • Invivogen (U.S.)
  • Lonza Group (Switzerland)
  • Merck Millipore (U.S.)
  • Promocell Gmbh (Germany)
  • R&D Systems, Inc. (U.S.)
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Estimation Methodology

2. Market Overview
2.1. Global Mycoplasma Testing Market: Evolution & Transition
2.2. Market Definition & Scope
2.3. Industry Structure
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360-Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Consumer Analysis And Key Buying Criteria
2.8. Competitive Analysis
2.8.1. Key Strategies & Analysis
2.8.2. Market Share Analysis
2.8.3. Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers
3.1.1. Increasing Funding for Life Science Research Activities
3.1.2. Increasing Number of Biotechnology & Pharmaceutical Firms
3.1.3. Increasing Demand for Pcr Based Assays
3.1.4. Technological Developments
3.1.5. Increasing Prevalence of Mycoplasma Infection Across the Globe
3.2. Market Restraints
3.2.1. Stringent Government Regulations
3.2.2. High Cost Associated With Mycoplasma Testing
3.3. Market Opportunities
3.3.1. Increasing Healthcare Expenditure in Developing Countries
3.3.2. Growth in Pharmaceutical Outsourcing.
3.4. Market Challenges
3.4.1. Lack of Skilled Professionals

4. Market Segmentation
4.1. Global Mycoplasma Testing Market By Application
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Global Cell Line Testing Market
4.1.5.1.1. Adoption Scenario & Market Determinants
4.1.5.1.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.1.3. Top Players & Key Products
4.1.5.1.4. Key Conclusions
4.1.5.2. Global Virus Testing Market
4.1.5.2.1. Adoption Scenario & Market Determinants
4.1.5.2.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.2.3. Top Players & Key Products
4.1.5.2.4. Key Conclusions
4.1.5.3. Global End of Production Cells Testing Market
4.1.5.3.1. Adoption Scenario & Market Determinants
4.1.5.3.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.3.3. Top Players & Key Products
4.1.5.3.4. Key Conclusions
4.1.5.4. Global Other Mycoplasma Testing Applications Market
4.1.5.4.1. Adoption Scenario & Market Determinants
4.1.5.4.2. Market Estimations And Forecasts 2014-2023 ($ Million)
4.1.5.4.3. Top Players & Key Products
4.1.5.4.4. Key Conclusions
4.2. Global Mycoplasma Testing Market By Technology
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Global Pcr Mycoplasma Testing Market
4.2.5.1.1. Application
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.1.4. Top Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Global Dna Staining Mycoplasma Testing Market
4.2.5.2.1. Application
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.2.4. Top Players & Key Products
4.2.5.2.5. Key Conclusions
4.2.5.3. Global Direct Assay Mycoplasma Testing Market
4.2.5.3.1. Application
4.2.5.3.2. Adoption Scenario & Market Determinants
4.2.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.3.4. Top Players & Key Products
4.2.5.3.5. Key Conclusions
4.2.5.4. Global Indirect Assay Mycoplasma Testing Market
4.2.5.4.1. Application
4.2.5.4.2. Adoption Scenario & Market Determinants
4.2.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.4.4. Top Players & Key Products
4.2.5.4.5. Key Conclusions
4.2.5.5. Global Enzymatic Methods Mycoplasma Testing Market
4.2.5.5.1. Application
4.2.5.5.2. Adoption Scenario & Market Determinants
4.2.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.5.4. Top Players & Key Products
4.2.5.5.5. Key Conclusions
4.2.5.6. Global Elisa Mycoplasma Testing Market
4.2.5.6.1. Application
4.2.5.6.2. Adoption Scenario & Market Determinants
4.2.5.6.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.6.4. Top Players & Key Products
4.2.5.6.5. Key Conclusions
4.2.5.7. Global Microbial Culture Techniques Mycoplasma Testing Market
4.2.5.7.1. Application
4.2.5.7.2. Adoption Scenario & Market Determinants
4.2.5.7.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.2.5.7.4. Top Players & Key Products
4.2.5.7.5. Key Conclusions
4.3. Global Mycoplasma Testing Market By End-User
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Global Mycoplasma Testing Market in Cell Banks
4.3.5.1.1. Application
4.3.5.1.2. Adoption Scenario & Market Determinants
4.3.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.1.4. Top Players & Key Products
4.3.5.1.5. Key Conclusions
4.3.5.2. Global Mycoplasma Testing Market in Academic Research Institutions
4.3.5.2.1. Application
4.3.5.2.2. Adoption Scenario & Market Determinants
4.3.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.2.4. Top Players & Key Products
4.3.5.2.5. Key Conclusions
4.3.5.3. Global Mycoplasma Testing Market in Contract Research Organizations
4.3.5.3.1. Application
4.3.5.3.2. Adoption Scenario & Market Determinants
4.3.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.3.4. Top Players & Key Products
4.3.5.3.5. Key Conclusions
4.3.5.4. Global Mycoplasma Testing Market in Pharmaceutical & Biotechnology Companies
4.3.5.4.1. Application
4.3.5.4.2. Adoption Scenario & Market Determinants
4.3.5.4.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.4.4. Top Players & Key Products
4.3.5.4.5. Key Conclusions
4.3.5.5. Global Mycoplasma Testing Market in Other End-Users
4.3.5.5.1. Application
4.3.5.5.2. Adoption Scenario & Market Determinants
4.3.5.5.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.3.5.5.4. Top Players & Key Products
4.3.5.5.5. Key Conclusions
4.4. Global Mycoplasma Testing Market By Product
4.4.1. Market Definition And Scope
4.4.2. Decision Support Database & Estimation Methodology
4.4.3. Comparative Analysis Across Market Segments
4.4.4. Opportunity Matrix
4.4.5. Market Segmentation
4.4.5.1. Global Mycoplasma Testing Kits & Reagents Market
4.4.5.1.1. Application
4.4.5.1.2. Adoption Scenario & Market Determinants
4.4.5.1.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.1.4. Top Players & Key Products
4.4.5.1.5. Key Conclusions
4.4.5.2. Global Mycoplasma Testing Instruments Market
4.4.5.2.1. Application
4.4.5.2.2. Adoption Scenario & Market Determinants
4.4.5.2.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.2.4. Top Players & Key Products
4.4.5.2.5. Key Conclusions
4.4.5.3. Global Mycoplasma Testing Services Market
4.4.5.3.1. Application
4.4.5.3.2. Adoption Scenario & Market Determinants
4.4.5.3.3. Market Estimations And Forecasts 2014-2023 ($ Million)
4.4.5.3.4. Top Players & Key Products
4.4.5.3.5. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of Mergers And Acquisition
5.1.2. List of Joint Ventures
5.1.3. List of Product Launches
5.1.4. List of Partnerships
5.2. Top 10 Company Analysis

6. Geographical Analysis
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Global Mycoplasma Testing Market By Region 2014-2023 ($ Million)
6.4.1. North America
6.4.1.1. Industry Analysis 2014-2023 ($ Million)
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.1.2. Top Players & Key Products
6.4.1.2.1.3. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.1.2.2.2. Top Players & Key Products
6.4.1.2.2.3. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Analysis 2014-2023 ($ Million)
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.1.2. Top Players & Key Products
6.4.2.2.1.3. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.2.2. Top Players & Key Products
6.4.2.2.2.3. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.3.2. Top Players & Key Products
6.4.2.2.3.3. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.4.2. Top Players & Key Products
6.4.2.2.4.3. Key Conclusions
6.4.2.2.5. Rest of Europe
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.2.2.5.2. Top Players & Key Products
6.4.2.2.5.3. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Analysis 2014-2023 ($ Million)
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.1.2. Top Players & Key Products
6.4.3.2.1.3. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.2.2. Top Players & Key Products
6.4.3.2.2.3. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.3.2. Top Players & Key Products
6.4.3.2.3.3. Key Conclusions
6.4.3.2.4. Australia
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.4.2. Top Players & Key Products
6.4.3.2.4.3. Key Conclusions
6.4.3.2.5. Rest of Asia Pacific
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.3.2.5.2. Top Players & Key Products
6.4.3.2.5.3. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Analysis 2014-2023 ($ Million)
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.1.2. Top Players & Key Products
6.4.4.2.1.3. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2023 ($ Million)
6.4.4.2.2.2. Top Players & Key Products
6.4.4.2.2.3. Key Conclusions

7. Company Profiles
7.1. ATCC Company (U.S.)
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Innovation Sector
7.1.4. Strategic Initiatives
7.1.5. SCOT Analysis
7.1.6. Strategic Analysis
7.2. Biological Industries (U.S.)
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Innovation Sector
7.2.4. Strategic Initiatives
7.2.5. SCOT Analysis
7.2.6. Strategic Analysis
7.3. Bionique Testing Laboratories, Inc. (U.S.)
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Innovation Sector
7.3.4. Strategic Initiatives
7.3.5. SCOT Analysis
7.3.6. Strategic Analysis
7.4. Charles River Laboratories, Inc. (U.S.)
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Innovation Sector
7.4.4. Strategic Initiatives
7.4.5. SCOT Analysis
7.4.6. Strategic Analysis
7.5. Eurofins Scientific S.A. (U.S.)
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Innovation Sector
7.5.4. Strategic Initiatives
7.5.5. SCOT Analysis
7.5.6. Strategic Analysis
7.6. Gibraltar Laboratories Inc. (U.S.)
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Innovation Sector
7.6.4. Strategic Initiatives
7.6.5. SCOT Analysis
7.6.6. Strategic Analysis
7.7. Invivogen (U.S.)
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Innovation Sector
7.7.4. Strategic Initiatives
7.7.5. SCOT Analysis
7.7.6. Strategic Analysis
7.8. Lonza Group (Switzerland)
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Innovation Sector
7.8.4. Strategic Initiatives
7.8.5. SCOT Analysis
7.8.6. Strategic Analysis
7.9. Merck Millipore (U.S.)
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Innovation Sector
7.9.4. Strategic Initiatives
7.9.5. SCOT Analysis
7.9.6. Strategic Analysis
7.10. Meridian Bioscience, Inc. (U.S.)
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Innovation Sector
7.10.4. Strategic Initiatives
7.10.5. SCOT Analysis
7.10.6. Strategic Analysis
7.11. Minerva Biolabs Gmbh (Germany)
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Innovation Sector
7.11.4. Strategic Initiatives
7.11.5. SCOT Analysis
7.11.6. Strategic Analysis
7.12. Promocell Gmbh (Germany)
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Innovation Sector
7.12.4. Strategic Initiatives
7.12.5. SCOT Analysis
7.12.6. Strategic Analysis
7.13. R&D Systems, Inc. (U.S.)
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Innovation Sector
7.13.4. Strategic Initiatives
7.13.5. SCOT Analysis
7.13.6. Strategic Analysis
7.14. Roche Diagnostics (Switzerland)
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Innovation Sector
7.14.4. Strategic Initiatives
7.14.5. SCOT Analysis
7.14.6. Strategic Analysis
7.15. Thermo Fisher Scientific Inc. (U.S.)
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Innovation Sector
7.15.4. Strategic Initiatives
7.15.5. SCOT Analysis
7.15.6. Strategic Analysis

List of Tables
1. Global Mycoplasma Testing Market By Application 2014-2023 ($ Million)
2. Global Cell Line Testing Market By GEography 2014-2023 ($ Million)
3. Global Virus Testing Market By GEography 2014-2023 ($ Million)
4. Global End of Production Cells Testing Market By GEography 2014-2023 ($ Million)
5. Global Other Mycoplasma Testing Applications Market By GEography 2014-2023 ($ Million)
6. Global Mycoplasma Testing Market By Technology 2014-2023 ($ Million)
7. Global Pcr Mycoplasma Testing Market By GEography 2014-2023 ($ Million)
8. Global Dna Staining Mycoplasma Testing Market By GEography 2014-2023 ($ Million)
9. Global Direct Assay Mycoplasma Testing Market By GEography 2014-2023 ($ Million)
10. Global Indirect Assay Mycoplasma Testing Market By GEography 2014-2023 ($ Million)
11. Global Enzymatic Methods Mycoplasma Testing Market By GEography 2014-2023 ($ Million)
12. Global Elisa Mycoplasma Testing Market By GEography 2014-2023 ($ Million)
13. Global Mycoplasma Testing Market By End-User 2014-2023 ($ Million)
14. Global Mycoplasma Testing Market in Cell Banks By GEography 2014-2023 ($ Million)
15. Global Mycoplasma Testing Market in Academic Research Institutions By GEography 2014-2023 ($ Million)
16. Global Mycoplasma Testing Market in Contract Research Organizations By GEography 2014-2023 ($ Million)
17. Global Mycoplasma Testing Market in Pharmaceutical & Biotechnology Companies By GEography 2014-2023 ($ Million)
18. Global Mycoplasma Testing Market By Product 2014-2023 ($ Million)
19. Global Mycoplasma Testing Kits & Reagents Market By GEography 2014-2023 ($ Million)
20. Global Mycoplasma Testing Instruments Market By GEography 2014-2023 ($ Million)
21. Global Mycoplasma Testing Services Market By GEography 2014-2023 ($ Million)
22. North America Mycoplasma Testing Market 2014-2023 ($ Million)
23. Europe Mycoplasma Testing Market 2014-2023 ($ Million)
24. Asia Pacific Mycoplasma Testing Market 2014-2023 ($ Million)
25. Rest of the World Mycoplasma Testing Market 2014-2023 ($ Million)

List of Figures
1. Global Mycoplasma Testing Market 2014-2023 ($ Million)
2. Global Cell Line Testing Market 2014-2023 ($ Million)
3. Global Virus Testing Market 2014-2023 ($ Million)
4. Global End of Production Cells Testing Market 2014-2023 ($ Million)
5. Global Other Mycoplasma Testing Applications Market 2014-2023 ($ Million)
6. Global Pcr Mycoplasma Testing Market 2014-2023 ($ Million)
7. Global Dna Staining Mycoplasma Testing Market 2014-2023 ($ Million)
8. Global Direct Assay Mycoplasma Testing Market 2014-2023 ($ Million)
9. Global Indirect Assay Mycoplasma Testing Market 2014-2023 ($ Million)
10. Global Enzymatic Methods Mycoplasma Testing Market 2014-2023 ($ Million)
11. Global Elisa Mycoplasma Testing Market 2014-2023 ($ Million)
12. Global Mycoplasma Testing Market in Cell Banks 2014-2023 ($ Million)
13. Global Enzymatic Methods Mycoplasma Testing Market 2014-2023 ($ Million)
14. Global Elisa Mycoplasma Testing Market 2014-2023 ($ Million)
15. Global Mycoplasma Testing Market in Cell Banks 2014-2023 ($ Million)
16. Global Mycoplasma Testing Market in Academic Research Institutions 2014-2023 ($ Million)
17. Global Mycoplasma Testing Market in Contract Research Organizations 2014-2023 ($ Million)
18. Global Mycoplasma Testing Market in Pharmaceutical & Biotechnology Companies
19. Global Mycoplasma Testing Kits & Reagents Market 2014-2023 ($ Million)
20. Global Mycoplasma Testing Instruments Market 2014-2023 ($ Million)
21. Global Mycoplasma Testing Services Market 2014-2023 ($ Million)
22. United States (U.S.) Mycoplasma Testing Market 2014-2023 ($ Million)
23. Canada Mycoplasma Testing Market 2014-2023 ($ Million)
24. United Kingdom (Uk) Mycoplasma Testing Market 2014-2023 ($ Million)
25. France Mycoplasma Testing Market 2014-2023 ($ Million)
26. Germany Mycoplasma Testing Market 2014-2023 ($ Million)
27. Spain Mycoplasma Testing Market 2014-2023 ($ Million)
28. Roe Mycoplasma Testing Market 2014-2023 ($ Million)
29. India Mycoplasma Testing Market 2014-2023 ($ Million)
30. China Mycoplasma Testing Market 2014-2023 ($ Million)
31. Japan Mycoplasma Testing Market 2014-2023 ($ Million)
32. Australia Mycoplasma Testing Market 2014-2023 ($ Million)
33. Roapac Mycoplasma Testing Market 2014-2023 ($ Million)
34. Latin America Mycoplasma Testing Market 2014-2023 ($ Million)
35. Mena Mycoplasma Testing Market 2014-2023 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ATCC Company (U.S.)
  • Biological Industries (U.S.)
  • Bionique Testing Laboratories, Inc. (U.S.)
  • Charles River Laboratories, Inc. (U.S.)
  • Eurofins Scientific S.A. (U.S.)
  • Gibraltar Laboratories Inc. (U.S.)
  • Invivogen (U.S.)
  • Lonza Group (Switzerland)
  • Merck Millipore (U.S.)
  • Meridian Bioscience, Inc. (U.S.)
  • Minerva Biolabs Gmbh (Germany)
  • Promocell Gmbh (Germany)
  • R&D Systems, Inc. (U.S.)
  • Roche Diagnostics (Switzerland)
  • Thermo Fisher Scientific Inc. (U.S.)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll